The efficacy of rofecoxib 50 mg and hydrocodone/acetamino­phen 7.5/750 mg in patients with post-arthroscopic pain

References

• Veterans Health Administration and Department of Defense. Clinical practice guideline for the management of postoperative pain, 2005. Available at http://www.oqp.med.va.gov/cpg/PAIN/PAIN_base.htm [accessed November 9, 2005]
   Google Scholar
• Rosenquist RW, Rosenberg J. Postoperative pain guidelines. Reg Anesth Pain Med 2003;28:279–88
   PubMed Web of Science ®Google Scholar
• American Society of Anesthesiologists Task Force on Acute Pain Management. Practice guidelines for acute pain management in the perioperative setting: an updated report. Anesthesiology 2004;100:1573–81
   PubMed Web of Science ®Google Scholar
• Institute for Clinical Systems Improvement. Assessment and management of acute pain, 2004. Available at http://www.icsi.org/knowledge/ [last accessed November 9, 2005]
   Google Scholar
• Verburg KM, Maziasz TJ, Weiner E, et al. Cox-2-specific inhibitors: definition of a new therapeutic concept. Am J Ther 2001;8:49–64
   PubMedGoogle Scholar
• Kehlet H, Dahl JB. Are perioperative anti-inflammatory drugs ulcerogenic in the short term? Drugs 1992;44(Suppl 5):38–41
   PubMedGoogle Scholar
• Hawkey CJ. COX-2 inhibitors. Lancet 1999;353:307–14
   PubMed Web of Science ®Google Scholar
• Cronstein BN. Cyclooxygenase-2-selective inhibitors: translating pharmacology into clinical utility. Cleve Clin J Med 2002;69\(Suppl 1):SI13–9
   Google Scholar
• Hawkey CJ, Laine L, Simon T, et al. Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind study. Gut 2003;52:820–6
   PubMed Web of Science ®Google Scholar
• Hawkey C, Laine L, Simon T, et al. Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial [The Rofecoxib Osteoarthritis Endoscopy Multinational Study Group]. Arthritis Rheum 2000;43:370–7
   PubMed Web of Science ®Google Scholar
• Lanza FL, Rack MF, Simon TJ, et al. Specific inhibition of cyclooxygenase-2 with MK-0966 is associated with less gastroduodenal damage than either aspirin or ibuprofen. Aliment Pharmacol Ther 1999;13:761–7
   PubMed Web of Science ®Google Scholar
• Sigthorsson G, Crane R, Simon T, et al. COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin. Gut 2000;47:527–32
   PubMed Web of Science ®Google Scholar
• Hegi TR, Bombeli T, Seifert B, et al. Effect of rofecoxib on platelet aggregation and blood loss in gynaecological and breast surgery compared with diclofenac. Br J Anaesth 2004;92:523–31
   PubMed Web of Science ®Google Scholar
• Ilan DI, Liporace FA, Rosen J, Cannavo D. Efficacy of rofecoxib for pain control after knee arthroscopy: a prospective, randomized, double-blinded clinical trial. Arthroscopy 2004;20:813–8
   PubMed Web of Science ®Google Scholar
• Reuben SS, Bhopatkar S, Maciolek H, et al. The preemptive analgesic effect of rofecoxib after ambulatory arthroscopic knee surgery. Anesth Analg 2002;94:55–9
   PubMed Web of Science ®Google Scholar
• Karamanlioglu B, Alagol A, Turan FN. Preemptive oral rofecoxib plus postoperative intraarticular bupivacaine for pain relief after arthroscopic knee surgery. Agri 2005;17:29–33
   Google Scholar
• Malmstrom K, Daniels S, Kotey P, et al. Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trial. Clin Ther 1999;21:1653–63
   PubMed Web of Science ®Google Scholar
• Malmstrom K, Fricke JR, Kotey P, et al. A comparison of rofecoxib versus celecoxib in treating pain after dental surgery: a single-center, randomized, double-blind, placebo- and active comparator-controlled clinical trial. Clin Ther 2002;24:1549–60
   PubMed Web of Science ®Google Scholar
• Chang DJ, Fricke JR, Bird SR, et al. Rofecoxib versus codeine/ acetaminophen in postoperative dental pain: a double-blind, randomized, placebo- and active comparator-controlled clinical trial. Clin Ther 2001;23:1446–55
   PubMed Web of Science ®Google Scholar
• Chang DJ, Desjardins PJ, Bird SR, et al. Comparison of rofecoxib and a multidose oxycodone/acetaminophen regimen for the treatment of acute pain following oral surgery: a randomized controlled trial. Curr Med Res Opin 2004;20: 939–49
   PubMed Web of Science ®Google Scholar
• Chang DJ, Desjardins PJ, Chen E, et al. Comparison of the analgesic efficacy of rofecoxib and enteric-coated diclofenac sodium in the treatment of postoperative dental pain: a randomized, placebo-controlled clinical trial. Clin Ther 2002;24:490–503
   PubMed Web of Science ®Google Scholar
• Ehrich EW, Dallob A, De Lepeleire I, et al. Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model. Clin Pharmacol Ther 1999;65:336–47
   PubMed Web of Science ®Google Scholar
• Chang DJ, Bird SR, Bohidar NR, King T. Analgesic efficacy of rofecoxib compared with codeine/acetaminophen using a model of acute dental pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;100:e74–e80
   PubMedGoogle Scholar
• Korn S, Vassil TC, Kotey PN, Fricke Jr JR. Comparison of rofecoxib and oxycodone plus acetaminophen in the treatment of acute pain: a randomized, double-blind, placebo-controlled study in patients with moderate to severe postoperative pain in the third molar extraction model. Clin Ther 2004;26:769–78
   Google Scholar
• Fricke J, Varkalis J, Zwillich S, et al. Valdecoxib is more efficacious than rofecoxib in relieving pain associated with oral surgery. Am J Ther 2002;9:89–97
   PubMedGoogle Scholar
• Christensen KS and Cawkwell GD. Valdecoxib versus rofecoxib in acute postsurgical pain: results of a randomized controlled trial. J Pain Symptom Manage 2004;27:460–70
   Google Scholar
• Kellstein D, Ott D, Jayawardene S, Fricke J. Analgesic efficacy of a single dose of lumiracoxib compared with rofecoxib, celecoxib and placebo in the treatment of post-operative dental pain. Int J Clin Pract 2004;58:244–50
   PubMed Web of Science ®Google Scholar
• Jackson ID, Heidemann BH, Wilson J, et al. Double-blind, randomized, placebo-controlled trial comparing rofecoxib with dexketoprofen trometamol in surgical dentistry. Br J Anaesth 2004;92:675–80
   PubMed Web of Science ®Google Scholar
• Bracco P, Debernardi C, Coscia D, et al. Efficacy of rofecoxib and nimesulide in controlling postextraction pain in oral surgery: a randomised comparative study. Curr Med Res Opin 2004;20:107–12
   PubMed Web of Science ®Google Scholar
• Desjardins PJ, Mehlisch DR, Chang DJ, et al. The time to onset and overall analgesic efficacy of rofecoxib 50 mg: a meta-analysis of 13 randomized clinical trials. Clin J Pain 2005;21:241–50
   PubMed Web of Science ®Google Scholar
• Reicin A, Brown J, Jove M, et al. Efficacy of single-dose and multidose rofecoxib in the treatment of post-orthopedic surgery pain. Am J Orthop 2001;30:40–8
   PubMedGoogle Scholar
• Reuben SS, Fingeroth R, Krushell R, Maciolek H. Evaluation of the safety and efficacy of the perioperative administration of rofecoxib for total knee arthroplasty. J Arthroplasty 2002; 17:26–31
   PubMed Web of Science ®Google Scholar
• Buvanendran A, Kroin JS, Tuman KJ, et al. Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement: a randomized controlled trial. J Am Med Assoc 2003;290:2411–8
   PubMed Web of Science ®Google Scholar
• Skinner HB, Shintani EY. Results of a multimodal analgesic trial involving patients with total hip or total knee arthroplasty. Am J Orthop 2004;33:85–92
   PubMedGoogle Scholar
• Desjardins PJ, Black PM, Daniels S, et al. A randomized controlled study comparing rofecoxib, diclofenac sodium, and placebo in post-bunionectomy pain. Curr Med Res Opin 2004;20:1523–37
   PubMed Web of Science ®Google Scholar
• Karamanlioglu B, Turan A, Memis D, Ture M. Preoperative oral rofecoxib reduces postoperative pain and tramadol consumption in patients after abdominal hysterectomy. Anesth Analg 2004;98:1039–43
   PubMed Web of Science ®Google Scholar
• Reuben SS, Connelly NR. Postoperative analgesic effects of celecoxib or rofecoxib after spinal fusion surgery. Anesth Analg 2000;91:1221–5
   PubMed Web of Science ®Google Scholar
• Woolf CJ, Chong MS. Preemptive analgesia – treating postoperative pain by preventing the establishment of central sensitization. Anesth Analg 1993;77:362–79
   PubMed Web of Science ®Google Scholar
• Katz J. Pre-emptive analgesia: importance of timing. Can J Anaesth 2001;48:105–14
   PubMed Web of Science ®Google Scholar
• Ochroch EA, Mardini IA, Gottschalk A. What is the role of NSAIDs in pre-emptive analgesia? Drugs 2003;63:2709–23
   Google Scholar
• O’Hanlon DM, Thambipillai T, Colbert ST, et al. Timing of pre-emptive tenoxicam is important for postoperative analgesia. Can J Anaesth 2001;48:162–6
   PubMed Web of Science ®Google Scholar
• Strichartz GR, Berde CB. Local anesthetics. In: Miller RD, editor. Miller’s anesthesia, 6th ed. Philadelphia (PA): Elsevier; 2005. p. 573–604
   Google Scholar
• Verburg KM. Development of new guidelines for analgesics/ drugs intended for the treatment of pain. Presented at the Arthritis Advisory Committee meeting. Bethesda, MD. 2002. Available at: http://www.fda.gov/ohrms/dockets/ac/02/slides/3873s1.htm [last accessed September 7, 2006]
   Google Scholar
• Honig S. Clinical trials in acute musculoskeletal injury states. An analysis of methodology. Am J Med 1988;84:42–4
   Web of Science ®Google Scholar
• Ridgway D. Analgesics for acute pain: meeting the United States Food and Drug Administration’s requirements for proof of efficacy. Clin J Pain 2004;20:123–32
   PubMed Web of Science ®Google Scholar
• Cooper SA. Models for clinical assessment of oral analgesics. Am J Med 1983;75:24–9
   PubMed Web of Science ®Google Scholar
• Bresalier RS, Sandler RS, Quan H, et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemo-prevention trial. New Engl J Med 2005;352:1092–102
   PubMed Web of Science ®Google Scholar
• Solomon SD, McMurray JJ, Pfeffer MA, et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. New Engl J Med 2005;352:1071–80
   PubMed Web of Science ®Google Scholar
• Ilahi OA, Reddy J, Ahmad I. Deep venous thrombosis after knee arthroscopy: a meta-analysis. Arthroscopy 2005;21:727–30
   Google Scholar